Literature DB >> 12911315

BlmIII and BlmIV nonribosomal peptide synthetase-catalyzed biosynthesis of the bleomycin bithiazole moiety involving both in cis and in trans aminoacylation.

Liangcheng Du1, Mei Chen, Yang Zhang, Ben Shen.   

Abstract

Cloning and sequence analysis of the bleomycin (BLM) biosynthetic gene cluster predicted that the two nonribosomal peptide synthetases (NRPSs), BlmIV and BlmIII, are responsible for the biosynthesis of the BLM bithiazole moiety. BlmIV is a seven domain (C(2)-A(2)-PCP(2)-Cy(1)-A(1)-PCP(1)-Cy(0)) NRPS, and BlmIII is a three domain (A(0)-PCP(0)-Ox) NRPS. The three domains of Cy(1)-A(1)-PCP(1) residing on the BlmIV subunit, the four domains of Cy(0) residing on the BlmIV subunit, and A(0)-PCP(0)-Ox residing on the BlmIII subunit constitute the two thiazole-forming NRPS-1 and NRPS-0 modules, respectively. BlmIII-A(0) was predicted to be nonfunctional, raising the question of how the NRPS-0 module activates and loads the Cys substrate to its cognate BlmIII-PCP(0). The NRPS-0 module consists of domains residing on two different subunits, requiring precise protein-protein interaction. Here, we report the production of the BlmIV and BlmIII NRPSs as an excised domain(s), module, or intact subunit form and biochemical characterizations of the resultant enzymes in vitro for their roles in BLM bithiazole biosynthesis. Our results (a) confirm that BlmIII-A(0) is a naturally occurring nonfunctional mutant, (b) demonstrate that BlmIV-A(1) activates Cys and catalyzes both in cis aminoacylation of BlmIV-PCP(1) (for NRPS-1) and in trans aminoacylation of BlmIII-PCP(0) (for NRPS-0), and (c) reveal that the C-terminus of the BlmIV subunit, characterized by the unprecedented AGHDDD(G) and PGHDDG repeats, is absolutely required for in trans aminoacylation of BlmIII-PCP(0). These findings underscore the flexibility and versatility of NRPSs in both structure and mechanism for natural product biosynthesis and provide an outstanding opportunity to study the molecular recognition and protein-protein interaction mechanism in NRPS assembly line enzymology.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12911315     DOI: 10.1021/bi034817r

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

1.  In vivo characterization of nonribosomal peptide synthetases NocA and NocB in the biosynthesis of nocardicin A.

Authors:  Jeanne M Davidsen; Craig A Townsend
Journal:  Chem Biol       Date:  2012-02-24

Review 2.  Flavoenzymes: versatile catalysts in biosynthetic pathways.

Authors:  Christopher T Walsh; Timothy A Wencewicz
Journal:  Nat Prod Rep       Date:  2013-01       Impact factor: 13.423

3.  Unusual activities of the thioesterase domain for the biosynthesis of the polycyclic tetramate macrolactam HSAF in Lysobacter enzymogenes C3.

Authors:  Lili Lou; Haotong Chen; Ronald L Cerny; Yaoyao Li; Yuemao Shen; Liangcheng Du
Journal:  Biochemistry       Date:  2011-12-23       Impact factor: 3.162

Review 4.  Natural products from thioester reductase containing biosynthetic pathways.

Authors:  Michael W Mullowney; Ryan A McClure; Matthew T Robey; Neil L Kelleher; Regan J Thomson
Journal:  Nat Prod Rep       Date:  2018-09-19       Impact factor: 13.423

Review 5.  Comparative analysis of the biosynthetic gene clusters and pathways for three structurally related antitumor antibiotics: bleomycin, tallysomycin, and zorbamycin.

Authors:  Ute Galm; Evelyn Wendt-Pienkowski; Liyan Wang; Sheng-Xiong Huang; Claudia Unsin; Meifeng Tao; Jane M Coughlin; Ben Shen
Journal:  J Nat Prod       Date:  2011-01-06       Impact factor: 4.050

6.  In vivo manipulation of the bleomycin biosynthetic gene cluster in Streptomyces verticillus ATCC15003 revealing new insights into its biosynthetic pathway.

Authors:  Ute Galm; Liyan Wang; Evelyn Wendt-Pienkowski; Runying Yang; Wen Liu; Meifeng Tao; Jane M Coughlin; Ben Shen
Journal:  J Biol Chem       Date:  2008-08-12       Impact factor: 5.157

7.  The biosynthetic gene cluster of zorbamycin, a member of the bleomycin family of antitumor antibiotics, from Streptomyces flavoviridis ATCC 21892.

Authors:  Ute Galm; Evelyn Wendt-Pienkowski; Liyan Wang; Nicholas P George; Tae-Jin Oh; Fan Yi; Meifeng Tao; Jane M Coughlin; Ben Shen
Journal:  Mol Biosyst       Date:  2008-11-12

8.  Functional characterization of tlmH in Streptoalloteichus hindustanus E465-94 ATCC 31158 unveiling new insight into tallysomycin biosynthesis and affording a novel bleomycin analog.

Authors:  Meifeng Tao; Liyan Wang; Evelyn Wendt-Pienkowski; Ningning Zhang; Dong Yang; Ute Galm; Jane M Coughlin; Zhinan Xu; Ben Shen
Journal:  Mol Biosyst       Date:  2009-12-01

9.  A designer bleomycin with significantly improved DNA cleavage activity.

Authors:  Sheng-Xiong Huang; Zhiyang Feng; Liyan Wang; Ute Galm; Evelyn Wendt-Pienkowski; Dong Yang; Meifeng Tao; Jane M Coughlin; Yanwen Duan; Ben Shen
Journal:  J Am Chem Soc       Date:  2012-08-06       Impact factor: 15.419

10.  Activation of a Cryptic Gene Cluster in Lysobacter enzymogenes Reveals a Module/Domain Portable Mechanism of Nonribosomal Peptide Synthetases in the Biosynthesis of Pyrrolopyrazines.

Authors:  Shanren Li; Xiuli Wu; Limei Zhang; Yuemao Shen; Liangcheng Du
Journal:  Org Lett       Date:  2017-09-12       Impact factor: 6.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.